New Treatment in Australia: A Promising Breakthrough for Reducing Body Weight?
Australia is closely watching the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist , representing a significant advance in addressing excess weight. Early clinical trials have demonstrated impressive results, showing greater impact than existing treatments like semaglutide. Whi